HER2 positive gastric cancer: Who benefits from HER2 targeted therapy? Conference

Kolbe, K, Haffner, I, Schierle, K et al. (2020). HER2 positive gastric cancer: Who benefits from HER2 targeted therapy? . 43(SUPPL 4), 156-157.

Industry Collaboration

cited authors

  • Kolbe, K; Haffner, I; Schierle, K; Maier, D; Geier, B; Luber, B; Kretzschmar, A; von Weikersthal, Fischer L; Ahlborn, M; Riera, J; Rau, B; Siegler, G; Fuxius, S; Decker, T; Wittekind, C; Lordick, F

authors

publication date

  • October 1, 2020

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

publisher

  • KARGER

start page

  • 156

end page

  • 157

volume

  • 43

issue

  • SUPPL 4